Physician profile
Tracie Roseberry
NPI 1104300607
$7,093.70
in general payments reported to CMS, 2019-2025
9 companies · $1,262 in 2025
The $1,262 reported for 2025 was more than what 91% of Acute Care (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $485 · 2022: $1,669 · 2023: $2,451 · 2024: $1,228 · 2025: $1,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,423 · Travel and Lodging: $1,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,422.88 |
| Travel and Lodging | $1,517.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $5,808.05 | 2021-2025 | Impella |
| Medtronic, INC. | $419.27 | 2021-2024 | Avalus, Penditure |
| Atricure, INC. | $182.92 | 2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Cvrx, INC. | $164.66 | 2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $149.17 | 2021 | |
| Medinc of Texas | $133.36 | 2022 | |
| Novo Nordisk INC | $121.84 | 2022 | |
| Bridgebio Pharma, INC. | $94.39 | 2025 | Attruby |
| Haemonetics Corporation | $20.04 | 2025 | Teg6s Hemostasis System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracie Roseberry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.